NYSE · SYKHealthcareSurgical Instruments

Stryker financials

$275.31+1.08%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
FY18
Dec 31
FY17
Dec 31
FY16
Dec 31
Revenue$25.12B$22.59B$20.50B$18.45B$17.11B$14.35B$14.88B$13.60B$12.44B$11.32B
Gross profit$16.07B$14.44B$13.06B$11.58B$10.97B$9.06B$9.70B$8.94B$8.18B$7.50B
Gross margin64.0%63.9%63.7%62.8%64.1%63.1%65.1%65.7%65.7%66.3%
Operating income$4.89B$3.69B$3.89B$2.84B$2.58B$2.22B$2.71B$2.54B$2.30B$2.17B
Net income$3.25B$2.99B$3.17B$2.36B$1.99B$1.60B$2.08B$3.55B$1.02B$1.65B
Net margin12.9%13.2%15.4%12.8%11.7%11.1%14.0%26.1%8.2%14.5%
Diluted EPS$8.40$7.76$8.25$6.17$5.21$4.20$5.48$9.34$2.68$4.35
EBITDA$6.25B$5.72B$4.95B$4.11B$3.57B$3.04B$3.49B$3.26B$2.94B$2.72B
Operating cash flow$5.04B$4.24B$3.71B$2.62B$3.26B$3.28B$2.19B$2.61B$1.56B$1.92B
Free cash flow$4.28B$3.49B$3.14B$2.04B$2.74B$2.79B$1.54B$2.04B$961.0M$1.43B
Diluted shares386.5M385.6M383.7M382.2M382.3M380.3M379.9M380.3M380.1M378.5M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$4.01B$3.65B$2.97B$1.84B$2.94B$2.94B
Short-term investments$89.0M$841.0M$82.0M$84.0M$75.0M$81.0M
Total debt$15.86B$13.60B$12.99B$13.05B$12.48B$13.99B
Total assets$47.84B$42.97B$39.91B$36.88B$34.63B$34.33B
Total liabilities$25.42B$22.34B$21.32B$20.27B$19.75B$21.25B
Shareholders' equity$22.42B$20.63B$18.59B$16.62B$14.88B$13.08B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology